Viking Therapeutics raises approximately $575 million through stock and note offerings
AI Summary- Viking Therapeutics closed concurrent upsized offerings of stock and convertible senior notes.
- $575 million was raised gross before underwriting discounts, commissions and offering expenses.
- Viking intends to fund VK2735, VK3019 and other corporate purposes.